Inflexion reaps 2.8x on £42m Phlexglobal sale to BDC
Inflexion Private Equity has sold Phlexglobal to Bridgepoint Development Capital (BDC) for £42m, generating a 2.8x return on its original investment.
More on Buyouts
AnaCap reaps 4.3x on MRH Trowe minority stake sale to TA Associates
German insurance broker will now be backed by both GPs; deal comes 2.5 years into AnaCap's investment period
Cinven’s indicative EUR 10 per share Synlab bid seen as below fair value
Sponsor listed the laboratory testing service provider at EUR 18 per share in 2020
MML buys majority stake in sponsor-backed Freeland
Existing investors IDI and Chevrillon will reinvest in the France-based freelance HR and IT platform as part of the SBO
Synova kicks off new fund deployment with Learnlight acquisition
Investment in Spanish edtech platform is the first from GBP 875m vehicle raised in three months last year
Latest News
Quadrivio plans first close for EUR 500m Lifestyle Fund II by mid-2023
Italy-based GP will expand predecessor Made in Italy vehicle’s focus beyond Italy to target European SMEs
AnaCap reaps 4.3x on MRH Trowe minority stake sale to TA Associates
German insurance broker will now be backed by both GPs; deal comes 2.5 years into AnaCap's investment period
Bregal poaches Carlyle exec for new chief investment officer role
Ryan Selwood’s appointment follows other recent senior hires, including a chief people officer and a chief technology officer
Cinven’s indicative EUR 10 per share Synlab bid seen as below fair value
Sponsor listed the laboratory testing service provider at EUR 18 per share in 2020